James N. Oak

1.2k total citations
7 papers, 990 citations indexed

About

James N. Oak is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, James N. Oak has authored 7 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 2 papers in Genetics. Recurrent topics in James N. Oak's work include Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). James N. Oak is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (3 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). James N. Oak collaborates with scholars based in Canada and United States. James N. Oak's co-authors include Hubert H.M. Van Tol, Natalie Lavine, H H Van Tol, Fang Liu, Suhas A. Kotecha, John F. MacDonald, Beverley A. Orser, Michael Jackson, Yaël Perez and Nathalie Éthier and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Biochemistry.

In The Last Decade

James N. Oak

7 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James N. Oak Canada 6 538 525 160 156 100 7 990
H H Van Tol Canada 10 671 1.2× 798 1.5× 106 0.7× 93 0.6× 65 0.7× 14 1.2k
Karin E. Borgmann‐Winter United States 17 556 1.0× 540 1.0× 177 1.1× 227 1.5× 55 0.6× 29 1.5k
Ingrid K. Svenson United States 12 249 0.5× 578 1.1× 105 0.7× 114 0.7× 163 1.6× 13 1.2k
Laura Mantoan Ritter United Kingdom 13 278 0.5× 611 1.2× 301 1.9× 298 1.9× 49 0.5× 33 1.1k
Tatsuyo Suzuki Japan 17 470 0.9× 456 0.9× 247 1.5× 230 1.5× 75 0.8× 30 1.1k
A. Magariello Italy 17 195 0.4× 288 0.5× 83 0.5× 120 0.8× 85 0.8× 41 773
Kazuhiko Toyooka Japan 10 328 0.6× 540 1.0× 102 0.6× 261 1.7× 74 0.7× 13 938
Håkan Garpenstrand Sweden 20 381 0.7× 395 0.8× 119 0.7× 237 1.5× 256 2.6× 33 1.2k
J.E. Kleinman United States 17 484 0.9× 703 1.3× 355 2.2× 368 2.4× 79 0.8× 31 1.4k
Martilias S. Farrell United States 15 575 1.1× 631 1.2× 83 0.5× 283 1.8× 64 0.6× 25 1.3k

Countries citing papers authored by James N. Oak

Since Specialization
Citations

This map shows the geographic impact of James N. Oak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James N. Oak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James N. Oak more than expected).

Fields of papers citing papers by James N. Oak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James N. Oak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James N. Oak. The network helps show where James N. Oak may publish in the future.

Co-authorship network of co-authors of James N. Oak

This figure shows the co-authorship network connecting the top 25 collaborators of James N. Oak. A scholar is included among the top collaborators of James N. Oak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James N. Oak. James N. Oak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Craenenbroeck, Kathleen Van, Stewart D. Clark, Michael J. Cox, et al.. (2005). Folding Efficiency Is Rate-limiting in Dopamine D4 Receptor Biogenesis. Journal of Biological Chemistry. 280(19). 19350–19357. 96 indexed citations
2.
Kotecha, Suhas A., James N. Oak, Michael Jackson, et al.. (2002). A D2 Class Dopamine Receptor Transactivates a Receptor Tyrosine Kinase to Inhibit NMDA Receptor Transmission. Neuron. 35(6). 1111–1122. 181 indexed citations
3.
Lavine, Natalie, Nathalie Éthier, James N. Oak, et al.. (2002). G Protein-coupled Receptors Form Stable Complexes with Inwardly Rectifying Potassium Channels and Adenylyl Cyclase. Journal of Biological Chemistry. 277(48). 46010–46019. 155 indexed citations
4.
Oak, James N., Natalie Lavine, & H H Van Tol. (2001). Dopamine D4and D2LReceptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent ontrans-Activation of the Platelet-Derived Growth Factor Receptor. Molecular Pharmacology. 60(1). 92–103. 109 indexed citations
5.
Oak, James N., Natalie Lavine, & Hubert H.M. Van Tol. (2001). Dopamine D4 and D2L Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans- Activation of the Platelet-Derived Growth Factor Receptor. Molecular Pharmacology. 60(1). 92–103. 4 indexed citations
6.
Oak, James N., et al.. (2000). The dopamine D4 receptor: one decade of research. European Journal of Pharmacology. 405(1-3). 303–327. 356 indexed citations
7.
Vickery, Ross G., Mordechai Anafi, James N. Oak, et al.. (1998). SH3 Binding Domains in the Dopamine D4 Receptor. Biochemistry. 37(45). 15726–15736. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026